Ecolab
ECL
$275.51
-0.24%
Ecolab, Inc. is a global leader in water, hygiene, and infection prevention solutions, producing and marketing cleaning and sanitation products, pest elimination services, and customized water management and cooling solutions for industrial manufacturing, data centers, hospitality, healthcare, and life sciences markets. The company is the undisputed global market share leader in its category, with a wide array of products and services including dish and laundry washing systems, pest control, and infection control products, and it maintains a particularly strong hold on the US market while expanding its international presence. The current investor narrative is dominated by Ecolab's bold $4.75 billion acquisition of CoolIT, a strategic pivot into the high-growth AI data center cooling market that has generated both excitement about the long-term growth opportunity and skepticism about the price and timing, as reflected in the stock's immediate decline following the announcement. This tension between the promise of AI-driven demand for advanced cooling solutions and concerns over integration risk, valuation, and near-term earnings dilution is the central debate driving attention around the stock right now.…
ECL
Ecolab
$275.51
Investment Opinion: Should I buy ECL Today?
We assign a Hold rating on Ecolab. The company's strong market position, accelerating revenue growth (10% YoY in Q1 2026), and robust profitability (ROE 21.2%) are compelling, but the stock's premium valuation (35.8x trailing PE, 24x EV/EBITDA) and the transformative $4.75 billion CoolIT acquisition introduce significant execution risk. The analyst consensus is 'buy' with an average target of $324.95 (17.7% upside), but we believe the risk/reward is balanced at current levels, warranting a neutral stance until greater clarity emerges on CoolIT integration and margin trends.
The supporting evidence for a Hold is mixed. On the positive side, revenue growth accelerated to 10.04% in Q1 2026, up from 4.8% in Q4 2025, and free cash flow remains robust at $1.87 billion TTM, providing ample capacity to fund the acquisition and dividend (1.01% yield, 36.3% payout ratio). However, the trailing PE of 35.81x is above the 2024 year-end level of 35.08x and the 2023 year-end level of 34.92x, suggesting a slight premium to recent history. The forward PE of 29.33x implies the market expects ~22% earnings growth, which is ambitious given gross margin compression of 77 basis points. Compared to the specialty chemicals sector, where EV/EBITDA often ranges from 10x to 15x, Ecolab's 24x multiple is rich and leaves little room for error.
The biggest risks that could invalidate our Hold rating are: (1) CoolIT integration challenges leading to earnings dilution beyond expectations, (2) sustained gross margin erosion below 43%, and (3) a broader market de-rating of premium growth stocks. We would upgrade to Buy if the stock pulls back to the $250-$260 range (implying a forward PE below 25x) or if CoolIT demonstrates tangible revenue synergies and margin accretion. We would downgrade to Sell if revenue growth decelerates below 5% or if gross margins fall below 42%, signaling structural pressures. Relative to its history and peers, ECL appears fairly valued to slightly overvalued, with the premium justified only by successful execution of its AI cooling pivot.
Sign up to view all
ECL 12-Month Price Forecast
Ecolab presents a balanced risk/reward profile. The company's fundamental momentum is improving, with revenue growth accelerating to 10% and strong cash flow generation, but the premium valuation and CoolIT integration risks warrant a neutral stance. The analyst consensus is bullish, yet the stock's significant underperformance versus the S&P 500 suggests the market is pricing in execution uncertainty. We would upgrade to bullish if CoolIT demonstrates tangible revenue synergies and gross margins stabilize above 44%, or if the stock pulls back to a more attractive valuation (forward PE below 25x). Conversely, we would downgrade to bearish if revenue growth decelerates below 5% or if gross margins fall below 42%, signaling structural challenges.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ecolab's 12-month outlook, with a consensus price target around $324.95 and implied upside of +17.9% versus the current price.
Average Target
$324.95
0 analysts
Implied Upside
+17.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$295 - $360
Analyst target range
Ecolab is covered by 21 analysts, with a consensus recommendation of "buy" and a recommendation mean of 1.54 (where 1 is a strong buy and 5 is a strong sell), indicating a bullish tilt. The average target price is $324.95, which implies an upside of approximately 17.7% from the current price of $276.18. The consensus is clearly bullish, with the average target well above the current price and the recommendation mean firmly in buy territory. This positive sentiment is supported by recent institutional ratings, which show mostly Buy or Outperform ratings from firms like Deutsche Bank, RBC Capital, Citigroup, and Jefferies, with UBS upgrading from Neutral to Buy in May 2026.
The target price range spans from a low of $295.00 to a high of $360.00, representing a spread of $65.00, or about 22% of the average target. The high target of $360.00 implies a 30.4% upside and likely assumes successful integration of CoolIT, accelerating growth in data center cooling, and multiple expansion. The low target of $295.00 implies a 6.8% upside and likely prices in more modest growth, potential margin pressures, and integration risks. The wide spread between the low and high targets signals significant uncertainty among analysts, which is understandable given the transformative nature of the CoolIT acquisition. The recent institutional ratings show a mix of reiterations and one upgrade, with no downgrades, suggesting that analyst sentiment is stable to improving. The estimated EPS average of $10.73 for the next fiscal year, with a range of $10.22 to $11.22, provides a fundamental anchor for these targets, and the estimated revenue average of $20.45 billion implies continued top-line growth.
Drowning in data?
Find the real signal!
Bulls vs Bears: ECL Investment Factors
The bull case rests on accelerating revenue growth (10% YoY in Q1 2026), strong profitability (ROE 21.2%), robust free cash flow ($1.87 billion), and a clear analyst consensus (buy rating, 17.7% upside). The bear case centers on a premium valuation (35.8x trailing PE, 24x EV/EBITDA), gross margin compression, and the transformative but risky $4.75 billion CoolIT acquisition. Currently, the bull evidence is stronger: the company's fundamental momentum is improving, and analyst sentiment remains firmly positive. However, the single most important tension is whether CoolIT can deliver sufficient growth to justify its price and reverse the stock's long-term underperformance. If CoolIT integration falters or AI cooling demand disappoints, the premium multiple could compress sharply, making this the key factor to monitor.
Bullish
- Revenue growth accelerating to 10%: Q1 2026 revenue of $4.066 billion grew 10.04% year-over-year, a sharp acceleration from 4.8% in Q4 2025 and 4.2% in Q3 2025. This suggests improving demand trends across Ecolab's core water and institutional segments, which together account for roughly 87% of total revenue.
- Analyst consensus bullish with 17.7% upside: 21 analysts rate ECL a 'buy' with a mean recommendation of 1.54, and the average target price of $324.95 implies 17.7% upside from the current $276.18. The low target of $295 still offers 6.8% upside, indicating that even the most cautious analyst sees positive returns.
- Strong profitability and ROE of 21.2%: Ecolab generates a trailing net margin of 12.91% and an operating margin of 18.11%, with a return on equity of 21.24%. These metrics reflect significant pricing power and efficient capital deployment, supporting the premium valuation.
- Robust free cash flow of $1.87 billion: Trailing twelve-month free cash flow of $1.87 billion provides ample capacity to fund the $4.75 billion CoolIT acquisition, service debt, and sustain the dividend. The interest coverage ratio of 8.56x further underscores financial flexibility.
Bearish
- Premium valuation leaves little room for error: ECL trades at a trailing PE of 35.81x and EV/EBITDA of 24.02x, well above the specialty chemicals sector's typical 10-15x EV/EBITDA range. The forward PE of 29.33x already prices in ~22% earnings growth, so any disappointment could trigger a sharp de-rating.
- Gross margin compression of 77 basis points: Q1 2026 gross margin fell to 43.55% from 44.32% a year earlier, reflecting input cost pressures or unfavorable mix. While operating margin held up, sustained gross margin erosion could undermine the premium multiple.
- CoolIT acquisition raises integration and leverage risks: The $4.75 billion CoolIT deal is a major pivot into AI data center cooling, a market where Ecolab has limited track record. The acquisition will increase debt-to-equity above the current 0.965 and could dilute near-term earnings if integration stumbles.
- Significant underperformance versus S&P 500: ECL has gained only 0.47% over the past year, vastly underperforming the S&P 500's 16.22% gain, resulting in a relative strength of -15.75%. This persistent underperformance may reflect investor skepticism about growth prospects or valuation.
ECL Technical Analysis
Ecolab is in a sustained, if unspectacular, uptrend, with the stock up 0.47% over the past year and 5.16% year-to-date, though it has significantly underperformed the S&P 500's 16.22% one-year gain. At a current price of $276.18, the stock is trading at approximately 50% of its 52-week range of $243.15 to $309.27, positioning it in the middle of its annual range rather than near highs or lows. This mid-range positioning suggests a market that is neither pricing in aggressive momentum nor deep pessimism, reflecting a balanced but cautious stance on the company's prospects. The 52-week high of $309.27 remains a distant 12% above the current price, while the 52-week low of $243.15 is 12% below, indicating a relatively symmetric risk profile around current levels.
Short-term momentum has been mixed and is diverging from the longer-term trend. The stock is down 0.81% over the past month, contrasting with a 4.06% gain over the past three months and a 0.73% gain over six months, suggesting a recent loss of upward momentum. This one-month decline occurred against a backdrop of a -1.06% decline in SPY, resulting in a relative strength of +0.25% over the past month, meaning Ecolab slightly outperformed the broader market during a weak period. However, the stock's one-year relative strength of -15.75% versus SPY highlights significant longer-term underperformance, and the 3-month relative strength of +1.02% suggests a modest recent stabilization. The recent pullback from the August high of $290.60 to the current $276.18, a decline of about 5%, indicates profit-taking or waning conviction after a summer rally.
Key technical levels are defined by the 52-week range, with support at the 52-week low of $243.15 and resistance at the 52-week high of $309.27. A breakout above $309.27 would signal renewed momentum and likely require a catalyst such as strong earnings or successful CoolIT integration, while a breakdown below $243.15 would signal a more serious bearish trend and could trigger further selling. The stock's beta of 0.89 indicates it is about 11% less volatile than the broader market, which is consistent with its defensive, non-cyclical business model and suggests lower risk for position sizing. The maximum drawdown of -20.31% over the past year reflects a moderate peak-to-trough decline, and the current short ratio of 3.31 indicates that short sellers have a moderate presence, with about 3.31 days of average volume needed to cover their positions.
Beta
0.89
0.89x market volatility
Max Drawdown
-20.3%
Largest decline past year
52-Week Range
$243-$309
Price range past year
Annual Return
+1.1%
Cumulative gain past year
| Period | ECL Return | S&P 500 |
|---|---|---|
| 1m | -0.2% | -2.0% |
| 3m | +0.6% | +1.4% |
| 6m | +5.2% | +15.0% |
| 1y | +1.1% | +15.7% |
| ytd | +4.9% | +11.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ECL Fundamental Analysis
Ecolab's revenue trajectory is solidly growing, with the most recent quarter (Q1 2026) reporting revenue of $4.066 billion, representing a 10.04% year-over-year increase from $3.695 billion in Q1 2025. This growth accelerated from the prior quarters, as Q4 2025 revenue of $4.196 billion grew 4.8% year-over-year from $4.005 billion, and Q3 2025 revenue of $4.165 billion grew 4.2% from $3.999 billion. The acceleration in Q1 2026 is notable and suggests improving demand trends, though the sequential decline from Q4 to Q1 is typical due to seasonality. Among the reported segments, Global Water is the largest at $2.043 billion, followed by Global Institutional and Specialty at $1.511 billion, Global Pest Elimination at $310.8 million, and Global Life Sciences at $200.9 million, with the water and institutional segments likely driving the bulk of growth given their scale and exposure to industrial and data center demand.
Profitability remains robust, with Q1 2026 net income of $432.6 million and a net margin of 10.64%, up from 10.89% in Q1 2025, while gross margin was 43.55% in Q1 2026 compared to 44.32% in Q1 2025, indicating a slight compression. The gross margin decline of about 77 basis points year-over-year is a concern, potentially reflecting input cost pressures or mix shifts, but the operating margin improved to 15.30% in Q1 2026 from 15.88% in Q1 2025, showing better cost control below the gross profit line. The company's net margin of 12.91% on a trailing basis is healthy for the specialty chemicals industry, and the operating margin of 18.11% demonstrates strong pricing power and operational efficiency. The slight compression in gross margin warrants monitoring, but the overall profitability profile remains strong and supportive of the investment case.
Ecolab's balance sheet is moderately leveraged, with a debt-to-equity ratio of 0.965 and a current ratio of 1.076, indicating adequate but not exceptional liquidity. The company generated $1.870 billion in trailing twelve-month free cash flow, which provides substantial internal funding capacity, though the Q1 2026 free cash flow was only $97.4 million due to a $348.5 million capital expenditure and a $318.6 million working capital drain. The return on equity of 21.24% is impressive and reflects efficient use of shareholder capital, while the return on assets of 7.23% is solid. The company's dividend yield of 1.01% and payout ratio of 36.31% indicate a sustainable dividend with room for growth, and the interest coverage ratio of 8.56 times provides a comfortable cushion for debt servicing. The CoolIT acquisition for $4.75 billion will likely increase leverage in the near term, but the strong cash flow generation should allow for deleveraging over time.
Quarterly Revenue
$4.1B
2026-03
Revenue YoY Growth
+10.0%
YoY Comparison
Gross Margin
43.5%
Latest Quarter
Free Cash Flow
$1.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ECL Overvalued?
Since Ecolab is profitable with positive net income of $432.6 million in the most recent quarter and trailing twelve-month earnings, the PE ratio is the appropriate primary valuation metric. The trailing PE ratio is 35.81x, while the forward PE is 29.33x, implying a significant gap that suggests the market expects earnings growth of approximately 22% over the next year, which is consistent with the analyst estimated EPS average of $10.73. This forward PE compression reflects optimism about the company's earnings trajectory, likely driven by the CoolIT acquisition and organic growth, but it also means the stock is priced for continued execution.
Compared to the specialty chemicals industry, Ecolab's trailing PE of 35.81x is at a premium, though a precise industry average is not provided in the data. However, the company's PS ratio of 4.62x and EV/EBITDA of 24.02x are elevated relative to typical chemical sector multiples, which often range between 10x and 15x for EV/EBITDA. The premium is justified by Ecolab's market leadership, strong margins, and recurring revenue model, but it leaves little room for error. The PEG ratio of -26.61 is not meaningful due to negative or distorted growth inputs, and the price-to-book ratio of 7.61x is high, reflecting the asset-light nature of the business and significant goodwill from acquisitions.
Historically, Ecolab's PE ratio has ranged from a low of around 24.55x in Q3 2024 to a high of 73.57x in Q1 2022, with the current 35.81x sitting in the middle of that range. The PS ratio of 4.62x is below the historical highs of 18x to 19x seen in 2021 and 2025, but the historical ratios data appears to have inconsistencies, possibly due to different calculation methodologies. The current PE of 35.81x is above the 2024 year-end level of 35.08x and the 2023 year-end level of 34.92x, suggesting the stock is trading at a slight premium to its recent historical average. This valuation suggests the market is pricing in optimistic expectations for growth, particularly from the AI cooling initiative, but it also means the stock could be vulnerable to a de-rating if growth disappoints.
PE
35.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 25x~56x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
24.0x
Enterprise Value Multiple
Investment Risk Disclosure
Ecolab's financial risks are moderate but rising. The debt-to-equity ratio of 0.965 will likely exceed 1.2 following the $4.75 billion CoolIT acquisition, increasing interest expense above the current $72.7 million per quarter. The current ratio of 1.076 provides a thin liquidity cushion, and Q1 2026 free cash flow was only $97.4 million due to a $318.6 million working capital drain and $348.5 million in capital expenditures. Gross margin compression of 77 basis points year-over-year (to 43.55%) signals input cost pressures or mix shifts that could persist if integration disrupts operations. Additionally, revenue concentration in Global Water (50% of sales) and Global Institutional (37%) means any slowdown in industrial or hospitality demand would disproportionately impact results.
Market and competitive risks are significant given the premium valuation. At 35.8x trailing earnings and 24x EV/EBITDA, ECL trades at a substantial premium to the specialty chemicals sector, leaving it vulnerable to multiple compression if growth disappoints. The stock's beta of 0.89 offers some downside protection, but its 15.75% underperformance versus the S&P 500 over the past year highlights waning investor confidence. The CoolIT acquisition pits Ecolab against established data center cooling players like Vertiv and Schneider Electric, and any execution missteps could cede market share. Regulatory risks are modest, but environmental regulations on water usage and chemical products could raise compliance costs. Recent news of the CoolIT deal triggered an immediate stock decline, reflecting skepticism about the price and timing, which could weigh on sentiment until tangible synergies emerge.
In a worst-case scenario, CoolIT integration fails to deliver expected revenue synergies, AI data center demand growth slows, and gross margin pressures intensify, leading to earnings misses and analyst downgrades. The stock could retest its 52-week low of $243.15, representing a 12% decline from the current $276.18. If the bear case fully materializes, shares could fall to the analyst low target of $295 (which is above current price, so the downside is more likely to the 52-week low) or lower if valuation multiples compress toward sector averages. A drop to $243 would equate to a loss of approximately 12%, while a more severe de-rating to 25x forward earnings on $10.73 EPS would imply a price near $268, only slightly below current levels. The maximum drawdown over the past year was -20.31%, suggesting that a 20% decline from recent highs is plausible in a stressed scenario, which would put the stock near $232, below the 52-week low.
FAQ
The key risks include: (1) Integration risk from the $4.75 billion CoolIT acquisition, which could lead to earnings dilution and increased leverage (debt-to-equity already at 0.965); (2) Margin pressure, with gross margin declining 77 basis points YoY to 43.55%, potentially eroding profitability; (3) Competitive threats in the data center cooling market from established players like Vertiv and Schneider Electric; and (4) Valuation risk, as the premium multiple (35.8x trailing PE) could compress if growth disappoints. Additionally, the stock's 15.75% underperformance versus the S&P 500 over the past year highlights waning investor confidence. These risks are ranked from highest to lowest severity, with integration and margin risks being the most immediate.
Our 12-month forecast for ECL includes three scenarios: a base case (55% probability) with a target range of $300-$330, assuming steady execution and EPS of $10.73; a bull case (25% probability) targeting $340-$360, driven by successful CoolIT integration and margin expansion; and a bear case (20% probability) targeting $243-$270, reflecting integration missteps and multiple compression. The most likely scenario is the base case, which aligns with the analyst average target of $324.95. The key assumption is that revenue grows 8-10% and gross margins stabilize around 43.5-44%. Investors should monitor quarterly earnings for signs of CoolIT traction and margin trends.
ECL appears fairly valued to slightly overvalued. Its trailing PE of 35.81x is above the 2024 year-end level of 35.08x and the 2023 year-end level of 34.92x, and its EV/EBITDA of 24.02x is well above the specialty chemicals sector's typical 10-15x range. The forward PE of 29.33x implies the market expects ~22% earnings growth, which is ambitious given gross margin compression of 77 basis points. Compared to peers, Ecolab commands a premium for its market leadership and recurring revenue, but this leaves little room for error. The market is pricing in successful execution of the CoolIT acquisition and sustained margin expansion; any disappointment could trigger a de-rating.
ECL is a good buy for long-term investors seeking a defensive, high-quality compounder with exposure to secular growth in water and data center cooling. The stock offers 17.7% upside to the analyst average target of $324.95, supported by accelerating revenue growth (10% YoY in Q1 2026) and a strong ROE of 21.2%. However, the premium valuation (35.8x trailing PE) and the $4.75 billion CoolIT acquisition introduce execution risk, making it less attractive for short-term traders. The biggest downside risk is a retest of the 52-week low of $243.15, representing a 12% decline. For risk-averse investors, waiting for a pullback to the $250-$260 range or for evidence of successful CoolIT integration would provide a better entry point.
ECL is best suited for long-term investment, with a suggested minimum holding period of 3-5 years. The company's defensive business model (beta 0.89), consistent dividend (1.01% yield, 36.3% payout ratio), and secular growth drivers in water and data center cooling support a buy-and-hold strategy. Short-term trading is less attractive due to the stock's recent lack of momentum (down 0.81% over the past month) and the overhang of the CoolIT integration. The stock's 52-week range of $243.15 to $309.27 suggests moderate volatility, but the long-term growth story remains intact. Investors should be prepared to weather potential near-term drawdowns of up to 20% (as seen in the past year's max drawdown of -20.31%) in exchange for potential long-term gains.
